BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25784245)

  • 1. Antibiotic therapy for ventilator-associated tracheobronchitis: a standard of care to reduce pneumonia, morbidity and costs?
    Craven DE; Hudcova J; Rashid J
    Curr Opin Pulm Med; 2015 May; 21(3):250-9. PubMed ID: 25784245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of ventilator-associated tracheobronchitis: to treat or not to treat?
    Craven DE; Hudcova J; Craven KA; Scopa C; Lei Y
    Curr Opin Crit Care; 2014 Oct; 20(5):532-41. PubMed ID: 25051351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.
    Abu-Salah T; Dhand R
    Adv Ther; 2011 Sep; 28(9):728-47. PubMed ID: 21833701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.
    Craven DE; Hjalmarson KI
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S59-66. PubMed ID: 20597674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population.
    Dallas J; Skrupky L; Abebe N; Boyle WA; Kollef MH
    Chest; 2011 Mar; 139(3):513-518. PubMed ID: 20724738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review.
    Russell CJ; Shiroishi MS; Siantz E; Wu BW; Patino CM
    BMC Pulm Med; 2016 Mar; 16():40. PubMed ID: 26956371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of ventilator-associated respiratory infections (VARI): microbiologic clues for tracheobronchitis (VAT) and pneumonia (VAP).
    Craven DE; Hudcova J; Lei Y
    Clin Chest Med; 2011 Sep; 32(3):547-57. PubMed ID: 21867822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes.
    Craven DE; Chroneou A; Zias N; Hjalmarson KI
    Chest; 2009 Feb; 135(2):521-528. PubMed ID: 18812452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Can We Distinguish Ventilator-Associated Tracheobronchitis from Pneumonia?
    Keane S; Vallecoccia MS; Nseir S; Martin-Loeches I
    Clin Chest Med; 2018 Dec; 39(4):785-796. PubMed ID: 30390749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial tracheobronchitis.
    Nseir S; Ader F; Marquette CH
    Curr Opin Infect Dis; 2009 Apr; 22(2):148-53. PubMed ID: 19276882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventilator-associated tracheobronchitis: pre-emptive, appropriate antibiotic therapy recommended.
    Craven DE; Hudcova J; Lei Y
    Crit Care; 2014 Nov; 18(6):627. PubMed ID: 25672436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized antibiotics in critically ill ventilated patients.
    Palmer LB
    Curr Opin Crit Care; 2009 Oct; 15(5):413-8. PubMed ID: 19657273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilator-associated tracheobronchitis (VAT): questions, answers, and a new paradigm?
    Craven DE
    Crit Care; 2008; 12(3):157. PubMed ID: 18598373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should We Treat Ventilator-Associated Tracheobronchitis with Antibiotics?
    Martin-Loeches I; Coakley JD; Nseir S
    Semin Respir Crit Care Med; 2017 Jun; 38(3):264-270. PubMed ID: 28578551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-emptive antibiotic therapy to reduce ventilator-associated pneumonia: "thinking outside the box".
    Craven DE; Hudcova J; Lei Y; Craven KA; Waqas A
    Crit Care; 2016 Sep; 20(1):300. PubMed ID: 27680980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia.
    Craven DE; Lei Y; Ruthazer R; Sarwar A; Hudcova J
    Am J Med; 2013 Jun; 126(6):542-9. PubMed ID: 23561632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia.
    Nseir S; Martin-Loeches I; Makris D; Jaillette E; Karvouniaris M; Valles J; Zakynthinos E; Artigas A
    Crit Care; 2014 Jun; 18(3):R129. PubMed ID: 24958136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.
    Martin-Loeches I; Povoa P; Rodríguez A; Curcio D; Suarez D; Mira JP; Cordero ML; Lepecq R; Girault C; Candeias C; Seguin P; Paulino C; Messika J; Castro AG; Valles J; Coelho L; Rabello L; Lisboa T; Collins D; Torres A; Salluh J; Nseir S;
    Lancet Respir Med; 2015 Nov; 3(11):859-68. PubMed ID: 26472037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic therapy in ventilator-associated tracheobronchitis: a literature review.
    Alves AE; Pereira JM
    Rev Bras Ter Intensiva; 2018 Mar; 30(1):80-85. PubMed ID: 29742211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study.
    Ramírez-Estrada S; Lagunes L; Peña-López Y; Vahedian-Azimi A; Nseir S; Arvaniti K; Bastug A; Totorika I; Oztoprak N; Bouadma L; Koulenti D; Rello J;
    Intensive Care Med; 2018 Aug; 44(8):1212-1220. PubMed ID: 30003304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.